bso cancer treatment glutathione

bso cancer treatment glutathione Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced chemo-ferrotherapy via sustainable elimination | Journal of Nanobiotechnology Disturbing the Redox Balance Using

Name: bso cancer treatment glutathione Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced chemo-ferrotherapy via sustainable elimination | Journal of Nanobiotechnology Disturbing the Redox Balance Using
Brand: hgidocs.co
SKU: 32589900070
Price: 23.57 USD
Availability: InStock
Rating: 4.5859000000000005 (8 reviews)

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways Glutathione (GSH) metabolism and druggable targets. Download Scientific Diagram Dual metabolic targeting liposomes potentiate triple negative breast cancer radiosensitivity via glucose and glutathione starvation ScienceDirect Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect

SKU: 32589900070 · From hgidocs.co

4.6

USD23.57 USD59.57

Pay in 4 interest-free payments of $5.89 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Some engineered tags also allow conditional control, such as pH or ligand-dependent stabilization, thus expanding their utility in synthetic biology and therapeutic design

Protein profile in Hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis

The association between IGF-1 levels and the histologic severity of nonalcoholic fatty liver disease

299 Uric acid deposition-induced inflammation, resulting in endothelial dysfunction and vascular damage (referred to as vascular gout), can occur at serum uric acid levels exceeding 6.5 mg/dL